A project supported by the Royal College of Psychiatrists aims to establish the largest database on medical cannabis use in Europe.
Up to 20000 patients in the UK will receive medical cannabis over a two-year period as part of a initiative which aims to create the largest body of data in Europe.
Although medical cannabis was legalized in the UK a year ago, it remains inaccessible to many patients. . "Medical cannabis is still out of reach for far too many people," said Professor David Nutt of Drug Science, the organization behind the launch of Project Twenty21, which will supply 20 patients with cannabis to 'by the end of 000.
“Patients are heavily in debt because of the cost of prescriptions from the private sector or are criminalized when they are forced to turn to the black market. They don't deserve any of this, and the statute of limitations needs to change. "
The project - which will be launched at and supported by the Royal College of Psychiatrists (RCP) - aims to create the largest body of data on medical cannabis in Europe, in order to convince policymakers that the plant should be made widely available as well. and affordable than other drugs.
Since legalization, doctors have been reluctant to prescribe cannabis due to the perceived lack of evidence of its effectiveness. They also fear that it may be overvalued by an emerging industry focused on maximizing profits.
The Twenty21 project will study the effects of cannabis on patients with chronic pain, epilepsy, multiple sclerosis, post-traumatic stress disorder, Tourette's syndrome, anxiety disorder or who have a history of substance abuse. .
"The PCR hopes that this project will address the lack of evidence on the use of medicinal cannabis products in all health settings, including mental health," said Professor Wendy Burn, President of the PCR .